SCHEMBL7702846

SCHEMBL7702846

CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(N)=O)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 8/20 0.65
SLC6A5 Q9Y345 2/20 0.56
EPHX2 P34913 2/20 0.55
FAAH O00519 5/20 0.54
MEN1 O00255 1/20 0.54
MAPK1 P28482 1/20 0.54
KMT2A Q03164 1/20 0.54
DNM1 Q05193 1/20 0.53
PLA2G2C Q5R387 1/20 0.49
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9017334 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL17204105 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL13279250 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL6536277 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL7705328 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL25175260 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL21724210 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL21724206 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL21724437 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1
SCHEMBL7699699 1.00 NOD1 (0.65) NOD1SLC6A5EPHX2FAAHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010055576-A1 CLEANSING COMPOSITION HONDA SHINKICHI (JP) 2001-12-27 US claimed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP claimed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO claimed
CN-118584095-A Use of intestinal contents as diarrhea markers 西北农林科技大学 2024-09-03 CN disclosed
WO-2023100260-A1 MARINE BIODEGRADABLE POLYMER COMPOUND, MARINE BIODEGRADATION PROMOTER, AND MARINE BIODEGRADABLE RESIN COMPOSITION 日清紡ホールディングス株式会社 2023-06-08 WO disclosed
US-11559071-B2 N-acyl-amino acid derivatives for improvement of the flavour profile of edible compositions GIVAUDAN SA (CH) 2023-01-24 US disclosed
US-11524933-B2 In or relating to organic compounds GIVAUDAN SA (CH) 2022-12-13 US disclosed
US-11492326-B2 Organic compounds GIVAUDAN SA (CH) 2022-11-08 US disclosed
CN-115297835-A Oily composition and cosmetic composition containing the same 株式会社ADEKA 2022-11-04 CN disclosed
US-9566218-B2 Production method of cosmetic, preparation method of gel for cosmetics, and method of reducing use amount of polymer thickener blended in cosmetic raw materials NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-02-14 US disclosed
US-9561255-B2 Cosmetic, external skin preparation, and medical instrument NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-02-07 US disclosed
US-20140113976-A1 PRODUCTION METHOD OF COSMETIC, PREPARATION METHOD OF GEL FOR COSMETICS, AND METHOD OF REDUCING USE AMOUNT OF POLYMER THICKENER BLENDED IN COSMETIC RAW MATERIALS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-04-24 US disclosed
EP-2692335-A1 METHOD FOR PRODUCING COSMETIC, METHOD FOR PREPARING GEL FOR COSMETICS, AND METHOD FOR REDUCING QUANTITY OF HIGH-MOLECULAR THICKENER ADDED TO STARTING MATERIALS OF COSMETIC Nissan Chemical Industries, Ltd. (JP) 2014-02-05 EP disclosed
EP-2664321-A2 Medical instrument Nissan Chemical Industries, Ltd. (JP) 2013-11-20 EP disclosed
US-20130084305-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2013-04-04 US disclosed
US-20120258059-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-10-11 US disclosed
EP-2494953-A1 COSMETIC AND EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT Nissan Chemical Industries, Ltd. (JP) 2012-09-05 EP disclosed
US-6350783-B2 CLEANING COMPOUND IS A N-LONG CHAIN ACYLAMINO ACID OR SALTS THEREOF, WHERE LONG CHAIN IS COCONUT OIL FATTY ACID OR PALM KERNEL OIL FATTY ACID, AND THE AMINO ACID IS GLUTAMINE OR ASPARAGINE KYOWA HAKKO KOGYO (JP) 2002-02-26 US disclosed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP disclosed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010055576-A1 CLEANSING COMPOSITION ELOVL1, ELOVL5, SGMS1 NOD1 3867/4885SLC6A5 3646/4885EPHX2 954/4885
US-20130084305-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT CUTA, F12, SGMS1 NOD1 3846/4885SLC6A5 3568/4885EPHX2 2115/4885
US-11492326-B2 Organic compounds GABRB3, GABRB2, GABRB1 NOD1 2388/4885SLC6A5 2041/4885EPHX2 3543/4885
US-20140113976-A1 PRODUCTION METHOD OF COSMETIC, PREPARATION METHOD OF GEL FOR COSMETICS, AND METHOD OF REDUCING USE AMOUNT OF POLYMER THICKENER BLENDED IN COSMETIC RAW MATERIALS CUTA, CETP, PLIN3 NOD1 4592/4885SLC6A5 481/4885EPHX2 3322/4885
US-20120258059-A1 COSMETIC, EXTERNAL SKIN PREPARATION, AND MEDICAL INSTRUMENT CUTA, F12, SGMS1 NOD1 3846/4885SLC6A5 3568/4885EPHX2 2115/4885
US-11524933-B2 In or relating to organic compounds GABRB3, GABRB1, GABRB2 NOD1 2489/4885SLC6A5 2155/4885EPHX2 3435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.